Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension

被引:86
作者
Dewachter, Laurence
Adnot, Serge
Fadel, Elie
Humbert, Marc
Maitre, Bernard
Barlier-Mur, Anne-Marie
Simonneau, Gerald
Hamon, Michel
Naeije, Robert
Eddahibi, Saadia
机构
[1] Hop Henri Mondor, AP HP, Dept Physiol, F-94010 Creteil, France
[2] Hop Marie Lannelongue, Serv Chirurgie Thorac Vasc & Transplant Cardiopul, UPRES EA 2705, F-92350 Le Plessis Robinson, France
[3] Hop Antoine Beclere, AP HP, Serv Pneumol, Clamart, France
[4] Univ Paris 06, INSERM, Fac Med Pitie Salpetriere, UMR 677, Paris, France
[5] Free Univ Brussels, Fac Med, Physiol Lab, Brussels, Belgium
关键词
angiopoietin-1; growth factors; idiopathic pulmonary arterial hypertension; pulmonary artery smooth muscle; pulmonary endothelial cells;
D O I
10.1164/rccm.200602-304OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Angiopoietins are involved in blood vessel maturation and remodeling. Objectives: One consequence of endothelium-specific tyrosine kinase-2 (Tie2) receptor activation by angiopoietin-1 (Ang1) is the release of endothelium-derived growth factors that recruit vascular wall cells. We investigated this process in idiopathic pulmonary arterial hypertension (iPAH). Methods: Ang1, Ang2, and total and phosphorylated Tie2 expression (mRNA and protein) was evaluated in human lung specimens and in cultured pulmonary artery smooth muscle cells (PA-SMCs) and pulmonary endothelial cells (P-ECs) isolated from patients with iPAH and control subjects. Media collected from Ang1-treated P-ECs were assessed for their PA-SMC growth-promoting effect. Measurements and Main Results: Tie2 receptor was fourfold higher in lungs and P-ECs from patients with iPAH than in those from control subjects, with a parallel increase in phosphorylated lung Tie2 receptor. In contrast, Ang1 and Ang2 expression in lungs, P-ECs, and PA-SMCs did not differ. Incubation of PA-SMCs with medium collected from P-EC cultures induced marked proliferation, and this effect was stronger when using P-ECs from patients with iPAH than from control subjects. Ang1 pretreatment of P-ECs from either patients or control subjects induced a further increase in PA-SMC proliferation. Fluoxetine, an inhibitor of the mitogenic action of serotonin, reduced the growth-promoting effect of P-EC media. Ang1 added to P-ECs from patients with iPAH increased the production of endothelin-1 (ET-1) and serotonin, but not of plateletderived growth factor-BB orepidermal growth factor, and increased the amount of mRNA encoding tryptophan hydroxylase-1 (the rate-limiting enzyme of serotonin synthesis), preproET-1, and ET-11-converting enzyme. Conclusions: The Ang1/Tie2 pathway is potentiated in iPAH, contributing to PA-SMC hyperplasia via increased stimulation of endothelium-derived growth factors synthesis by P-ECs.
引用
收藏
页码:1025 / 1033
页数:9
相关论文
共 36 条
[1]   Lessons learned from cancer may help in the treatment of pulmonary hypertension [J].
Adnot, S .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (06) :1461-1463
[2]   Endothelial/pericyte interactions [J].
Armulik, A ;
Abramsson, A ;
Betsholtz, C .
CIRCULATION RESEARCH, 2005, 97 (06) :512-523
[3]   Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide [J].
Babaei, S ;
Teichert-Kuliszewska, K ;
Zhang, QW ;
Jones, N ;
Dumont, DJ ;
Stewart, DJ .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (06) :1927-1936
[4]   Insight into the physiological functions of PDGF through genetic studies in mice [J].
Betsholtz, C .
CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (04) :215-228
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   Stable interaction between α5β1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1 [J].
Cascone, I ;
Napione, L ;
Maniero, F ;
Serini, G ;
Bussolino, F .
JOURNAL OF CELL BIOLOGY, 2005, 170 (06) :993-1004
[7]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[8]   A new animal model for pulmonary hypertension based on the overexpression of a single gene, angiopoietin-1 [J].
Chu, D ;
Sullivan, CC ;
Du, LL ;
Cho, AJ ;
Kido, M ;
Wolf, PL ;
Weitzman, MD ;
Jamieson, SW ;
Thistlethwaite, PA .
ANNALS OF THORACIC SURGERY, 2004, 77 (02) :449-456
[9]   Isolation of Angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning [J].
Davis, S ;
Aldrich, TH ;
Jones, PF ;
Acheson, A ;
Compton, DL ;
Jain, V ;
Ryan, TE ;
Bruno, J ;
Radziejewski, C ;
Maisonpierre, PC ;
Yancopoulos, GD .
CELL, 1996, 87 (07) :1161-1169
[10]  
Du Lingling, 2003, New England Journal of Medicine, V348, P500, DOI 10.1056/NEJMoa021650